Posted on 6 月 6, 20256/6/25
Comparing Long-Term HAE Treatments: Insights from a Robust Network Meta-Analysis
Posted on 5 月 23, 20255/23/25
Most Favored Nation Pricing | Insights and Implications for Manufacturers
Posted on 5 月 22, 20255/22/25
Demystifying Market Access: A Must-Read for Navigating the Lab-to-Patient Journey
Posted on 5 月 21, 20255/21/25
EVERSANA Returns as Global Host and Presenting Sponsor for Frontiers Health 2025
Posted on 5 月 15, 20255/15/25
Staying Ahead of the Curve in Pharmacovigilance: CIOMS XIV Draft “Artificial Intelligence in Pharmacovigilance”
Posted on 5 月 15, 20255/15/25
Staying Ahead of the Curve in Pharmacovigilance: Outcome of GVP Inspections by NPRA
Posted on 5 月 5, 20255/5/25
Staying Ahead of the Curve in Pharmacovigilance: Emerging Regulations and Their Implications in Saudi Arabia
Posted on 4 月 10, 20254/10/25